As of 2025-07-11, the Fair Value of Kalvista Pharmaceuticals Inc (KALV) is -15.73 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 15.51 USD, the upside of Kalvista Pharmaceuticals Inc is -201.40%.
With the market price of 15.51 USD and our fair value calculation, Kalvista Pharmaceuticals Inc (KALV) is not a good investment. Investing in KALV stocks now will result in a potential loss of 201.40%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-04-30 | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 5Y Avg | |
| Net income | -29.12 | -46.24 | -82.34 | -92.91 | -126.64 | -75.45 |
| YoY growth | -39.87% | -58.79% | -78.07% | -12.84% | -36.31% | -45.17% |
| Market Cap (mil) | 613.44 |
| P/E | |
| Forward P/E |
| EPS | -3.15 |
| Avg earnings growth rate | -45.17% |
| TTM earnings | -156.39 |